the preliminary results obtained in 212 patients from 20 intensive care units , suffering from pneumonia or nosocomial septicemia and treated at random with either ceftazidime + pefloxacin ( cp ) or ceftazidime + amikacin ( ca ) were analyzed .
C0036690
septicemia
C0002499
amikacin